Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02574624
Other study ID # VISIA
Secondary ID
Status Terminated
Phase N/A
First received September 24, 2015
Last updated September 25, 2017
Start date November 2015
Est. completion date September 2017

Study information

Verified date September 2017
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To Assess the Safety of Vitreous surgery with intraocular assistance (VISIA) & to identify and document with video evidence and surgeon's case report forms intraocular maneuvers that are facilitated by VISIA.


Description:

Standard care surgery will be done with a few novel additions to facilitate the surgical procedure. Currently 3 ports are inserted by creating holes in the sclera (white part of the eye) to enter into the posterior part of the eye. When complex dissection is needed, a fourth port will be inserted. The assistant will insert light source through the 4th port. This eliminates the need for the surgeon to hold the light in one hand. Hence allows freeing of both hands for the surgeon to use a forceps in one hand to grasp and elevate membranes and a scissors in the other to cut connections between the retina and the membranes. When membranes are particularly thick, it can be difficult to dissect with a single forceps holding up the membrane. In this situation, a 5th port will be inserted allowing the assistant to insert a light source through one and a forceps though another. The surgeon will have a forceps in one hand and a scissors in another making dissection process more efficient.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date September 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

All subjects must meet the following criteria to be eligible for study entry:

- Signed informed consent and authorization of use and disclosure of protected health information

- Age =18 years

- Subject will have complex retinal pathology for which it is judged that surgical objectives could be facilitated by VISIA

Exclusion Criteria:

Subjects who meet any of the following criteria will be ineligible for study entry:

• Patients with disease processes such as macular pucker and macular hole that are generally well-managed by standard two-handed vitrectomy.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Intraocular assistance
Intraocular assistance with help of surgical assistants during vitreous surgery (VISIA) in patients who require vitreous surgeries as part of standard of care procedure for conditions like retinal detachments, dislocated intraocular lens and glaucoma patients requiring endophotocoagulation.

Locations

Country Name City State
United States Wilmer Eye Institute, Johns Hopkins University School of Medicine Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome measure is recording of adverse events directly related to VISIA and adverse events unrelated to VISIA. 4 months
Secondary Surgeon's assessment of the benefits and risks of VISIA recorded on the surgical case report form. 4 months
Secondary Assistant's assessment of the benefits and risks of VISIA recorded on the surgical case report form. 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT06347302 - Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment N/A